Close to 130 industry and non-industry players, across the globe, claim to have the necessary expertise.

The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise

SHARE THIS POST :
Close to 130 industry and non-industry players, across the globe, claim to have the necessary expertise. <Roots>

The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise. Further, owing to its inherent hazardous nature, radiopharmaceuticals have a complex regulatory market authorization process. Consequently, a number of innovator companies have demonstrated a preference for outsourcing radiopharmaceutical manufacturing to contract service providers.

 

To order this 320+ page report, which features 45+ figures and 100+ tables, please visit this - https://www.roots-ysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html

The USD 6+ billion (by 2030) financial opportunity -ociated with nuclear medicine and radiopharmaceuticals manufacturing, has been -yzed across the following segments:

Target Disease Indication 

Breast Cancer

Chronic Lymphocytic Leukemia

Colorectal Cancer

Head and Neck Cancer

Lung Cancer

Lupus Nephritis

Melanoma

Multiple Myeloma

Primary Sjögren's Syndrome

Others 

Target Immune Checkpoint

B7-H3

CD38

CD40

CD47

Others

Mechanism of Action

Inhibitory

Stimulatory

Therapeutic Modality

Monoclonal Antibody

Small Molecule

Type of Therapy 

Monotherapy 

Combination Therapy

Route of Administration

Intravenous

Subcutaneous

Others

Key Geographical Regions 

North America

Europe

Asia-Pacific and the Rest of the World 

The Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030” report features the following companies, which we identified to be key players in this domain:

Advanced Accelerator Applications

Belgian Nuclear Research Center (SCK•CEN)

Cardinal Health

China Isotope & Radiation Corporation

Curium Pharma

-mBio

Eckert & Ziegler

Eczacibasi-Monrol

GE Healthcare

Jubilant DraxImage

Lantheus Medical Imaging

Nihon Medi-Physics

Nordion

PETNET Solutions

SinoTau Pharmaceuticals

SOFIE

Table of Contents

1. Preface

2. Executive Summary


3. Introduction
 

4. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Industry Players): Current Market Landscape
 

5. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Non-Industry Players): Current Market Landscape
 

6. Nuclear Medicine and Radiopharmaceuticals Manufacturers in North America
 

7. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Europe
 

8. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Asia-Pacific And Rest of The World
 

9. Nuclear Medicine and Radiopharmaceuticals Manufacturers: Company Compe-iveness -ysis
 

10. Partner-ps and Collaborations
 

11. Production and Supply Chain of Medical Isotope Molybdenum-99 (Technetium-99m)
 

12. Market Forecast and Opportunity -ysis
 

13. Concluding Remarks

14. Executive Insights

15. Appendix 1: Tabulated Data

16. Appendix 2: List of Companies and Organizations

To purchase a copy, please visit https://www.roots-ysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@roots-ysis.com